Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1826]
News [2739]
Articles [202]
Editorials [1]
Conferences [136]
elearning [13]
Gemcitabine plus cisplatin plus ipilimumab for metastatic urothelial cancer
Prof Matthew Galsky - The Mount Sinai Hospital, New York, USA
Gemcitabine plus cisplatin plus ipilimumab for metastatic urothelial cancer ( Prof Matthew Galsky - The Mount Sinai Hospital, New York, USA )
8 Jan 2016
Comparing adjuvant radiotherapy plus chemo vs. adjuvant chemo following...
Dr Brian Baumann - University of Pennsylvania, Philadelphia, USA
Comparing adjuvant radiotherapy plus chemo vs. adjuvant chemo following cystectomy for bladder cancer ( Dr Brian Baumann - University of Pennsylvania, Philadelphia, USA )
8 Jan 2016
Molecular genetics of testicular cancer: What does the clinician need to know?
Dr Katherine Nathanson - University of Pennsylvania, Philadelphia, USA
Molecular genetics of testicular cancer: What does the clinician need to know? ( Dr Katherine Nathanson - University of Pennsylvania, Philadelphia, USA )
8 Jan 2016
ASCO GU 2016: Highlights
Dr Toni Choueiri - Dana Farber Cancer Institute, Boston, USA
ASCO GU 2016: Highlights ( Dr Toni Choueiri - Dana Farber Cancer Institute, Boston, USA )
8 Jan 2016
Atezolizumab for platinum-treated locally advanced or metastatic urothelial...
Dr Jean Hoffman-Censits - Kimmel Cancer Center, Philadelphia, USA
Atezolizumab for platinum-treated locally advanced or metastatic urothelial carcinoma ( Dr Jean Hoffman-Censits - Kimmel Cancer Center, Philadelphia, USA )
8 Jan 2016
Actionable targets in patients with cisplatin-resistant advanced germ cell...
Dr Aditya Bagrodia - Memorial Sloan Kettering New York, USA
Actionable targets in patients with cisplatin-resistant advanced germ cell tumours ( Dr Aditya Bagrodia - Memorial Sloan Kettering New York, USA )
7 Jan 2016
Survival outcomes from the CALGB 40603 study in triple-negative breast cancer
Dr William Sikov - Women & Infants Hospital of Rhode Island, Providence, USA
Survival outcomes from the CALGB 40603 study in triple-negative breast cancer ( Dr William Sikov - Women & Infants Hospital of Rhode Island, Providence, USA )
17 Dec 2015
Molecular evolution of breast cancer during neoadjuvant chemotherapy
Prof Anne-Lise Børresen-Dale - Oslo University Hospital, Oslo, Norway
Molecular evolution of breast cancer during neoadjuvant chemotherapy ( Prof Anne-Lise Børresen-Dale - Oslo University Hospital, Oslo, Norway )
17 Dec 2015
Homologous recombination deficiency predicts neo-adjuvant chemotherapy response...
Dr Virginia Kaklamani - UT Health Science Center, San Antonio, TX
Homologous recombination deficiency predicts neo-adjuvant chemotherapy response in triple-negative breast cancer ( Dr Virginia Kaklamani - UT Health Science Center, San Antonio, TX )
17 Dec 2015
TAILORx: Genomic test helps identify low-risk women who do not need chemotherapy
Dr Virginia Kaklamani - UT Health Science Center, San Antonio, TX
TAILORx: Genomic test helps identify low-risk women who do not need chemotherapy ( Dr Virginia Kaklamani - UT Health Science Center, San Antonio, TX )
17 Dec 2015
Editor's choice for December 2015
Prof Gordon McVie - ecancer Editor
Editor's choice for December 2015 ( Prof Gordon McVie - ecancer Editor )
16 Dec 2015
Update on management of the axilla
Dr Terry Mamounas - UF Health Cancer Center, Orlando, USA
Update on management of the axilla ( Dr Terry Mamounas - UF Health Cancer Center, Orlando, USA )
14 Dec 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation